PRESS RELEASE published on 11/28/2023 at 12:40, 2 years 5 months ago The Phase 1a/1b Human Clinical Trial of NV-CoV-2, the Company’s Broad-Spectrum Antiviral Drug, Has Successfully Completed the First Part (Phase 1a), Reports NanoViricides
PRESS RELEASE published on 11/15/2023 at 12:45, 2 years 6 months ago NanoViricides Has Filed its Quarterly Report - NV-387 Broad-Spectrum Antiviral in Clinical Trials Has Additional Applications
PRESS RELEASE published on 11/14/2023 at 12:45, 2 years 6 months ago Broad-Spectrum Antiviral NV-387 (NV-CoV-2) in Phase 1a/1b Clinical Trial is Highly Effective in an Animal Model for MPox and Smallpox Drug Development
PRESS RELEASE published on 10/16/2023 at 12:45, 2 years 7 months ago NanoViricides, Inc. Has Filed its Annual Report: Broad-spectrum Antiviral NV-387 (NV-CoV-2) in Phase 1a/1b Clinical Trial is Highly Active Against Coronaviruses as well as RSV
PRESS RELEASE published on 10/12/2023 at 12:45, 2 years 7 months ago NanoViricides, Inc. to Present at the Partnership Opportunities in Drug Delivery Conference in Boston on October 16, 2023 at 6:07pm ET
PRESS RELEASE published on 08/21/2023 at 12:45, 2 years 9 months ago The Phase 1a/1b Human Clinical Trial of NV-CoV-2, the Company’s Broad-Spectrum Antiviral Drug, is Progressing Successfully, Reports NanoViricides
PRESS RELEASE published on 07/11/2023 at 12:45, 2 years 10 months ago Company’s Broad-Spectrum Antiviral NV-387 Has Demonstrated Excellent Effectiveness in RSV in a Lethal Lung Disease Animal Model, Reports NanoViricides
PRESS RELEASE published on 07/06/2023 at 12:45, 2 years 10 months ago Clinical Trial of Broad-Spectrum Antiviral Drug NV-CoV-2 is Progressing Well, Says NanoViricides - NV-CoV-2 is Positioned to Fulfill Many Unmet Medical Needs
PRESS RELEASE published on 06/29/2023 at 12:45, 2 years 10 months ago NanoViricides Announces that Clinical Trials of Its Broad-Spectrum Antiviral Drug NV-CoV-2 Have Begun
PRESS RELEASE published on 05/31/2023 at 12:40, 2 years 11 months ago NanoViricides, Inc. to Present at the BIO International Convention in Boston on June 5th, 2023 at 3:15pm ET
Published on 05/26/2026 at 17:40, 1 hour 6 minutes ago New Horizon Aircraft Ltd. Announces Pricing of $25 Million Offering of Common Shares
Published on 05/26/2026 at 14:30, 4 hours 16 minutes ago Klondike Gold Announces 2026 Diamond Drilling Program Underway to Update and Expand Gold Mineral Resources
Published on 05/26/2026 at 14:30, 4 hours 16 minutes ago Predictiv AI Announces Strategic Healthcare Partnership and CloudRep AI Integration with Clinicmaster Following Successful Multi-Clinic Pilot Deployments
Published on 05/26/2026 at 14:30, 4 hours 16 minutes ago In the Ebola Emergency, NV-387 is Ready to be Shipped to DRC, and It Compares Favorably as a Treatment for Ebola Versus Possible Options, Says NanoViricides
Published on 05/26/2026 at 14:15, 4 hours 31 minutes ago Worksport (NASDAQ:WKSP) Secures U.S. Patent For 'Industry-First' Zerofrost Heat Pump Through Its Subsidiary, Terravis Energy
Published on 05/26/2026 at 18:30, 16 minutes ago H2APEX publishes financial figures for the first quarter of 2026 and confirms forecast
Published on 05/26/2026 at 17:45, 1 hour ago FIGEAC AÉRO: EXTENSION DU PARTENARIAT AVEC UN CLIENT AMÉRICAIN
Published on 05/26/2026 at 17:30, 1 hour 15 minutes ago GEVELOT S.A.: Weekly declaration of share buybacks – 05/26/2026 (French only)
Published on 05/26/2026 at 17:30, 1 hour 15 minutes ago GEVELOT S.A.: Déclaration hebdomadaire de rachat d'actions 26 05 2026
Published on 05/26/2026 at 16:30, 2 hours 15 minutes ago M1 Kliniken AG: Capital reduction through cancellation of treasury shares successfully completed
Published on 05/26/2026 at 17:45, 1 hour 1 minute ago EURAZEO INVESTS IN BABYLON, A FRENCH OPERATOR OF NEXT-GENERATION APARTHOTELS
Published on 05/26/2026 at 17:45, 1 hour 1 minute ago EURAZEO INVESTIT DANS BABYLON, SPÉCIALISTE FRANÇAIS DES APARTHOTELS DE NOUVELLE GÉNÉRATION
Published on 05/26/2026 at 17:40, 1 hour 6 minutes ago LDC : Nombre total de droits de vote et d'actions composant le capital au 30.04.26.
Published on 05/26/2026 at 15:00, 3 hours 46 minutes ago Besluiten Gewone en Buitengewone Algemene Vergaderingen
Published on 05/26/2026 at 15:00, 3 hours 46 minutes ago Resolutions Ordinary and Extraordinary General Meetings
